News | August 12, 2014

MUSC Hollings Cancer Center Unveils New TrueBeam STx Installation

TrueBeam STx expands radiation oncology services, offers patients shorter treatment time

August 12, 2014 — New technology installed at the Medical University of South Carolina (MUSC) Hollings Cancer Center in Charleston offers patients a nonsurgical, specialized form of treatment that can be completed in five or fewer outpatient sessions, each lasting 20 minutes or less. The first patient will be treated on Aug. 13.

An investment made in partnership with national radiosurgery provider Alliance Oncology, TrueBeam STx by Varian Medical Systems is an advanced cancer treatment system that treats patients with stereotactic radiosurgery (SRS), a noninvasive method of treating tumors with high-dose radiation precisely matched to the size and shape of the tumor. This pinpoint accuracy minimizes radiation exposure to healthy tissue and allows physicians to customize treatment for different types of cancer, including more complex cases.

“TrueBeam STx will allow us to enhance the patient experience by significantly reducing treatment time to five or fewer visits, which will allow patients who receive the treatment to spend more time with their families and to focus on other activities,” said Joseph Jenrette III, M.D., chairman of the department of radiation oncology at MUSC. “TrueBeam STx can give hope to patients with inoperable or surgically complex tumors, as well as those seeking an alternative to surgery or conventional radiation therapy.”

TrueBeam STx is capable of treating cancerous and noncancerous tumors in the body, including the lung, brain, prostate, spine, liver, pancreas, kidney, bone and eye. It can also treat certain blood vessel abnormalities, as well as trigeminal neuralgia, a neuropathic disorder that causes intense facial pain.

Treatments with TrueBeam STx are available at the MUSC Health main campus in downtown Charleston and will be available in Mount Pleasant in early 2015. An open house will be held at the main hospital on Thursday, Aug. 14, from 4-6 p.m. and will include demonstrations of the new technology.

For more information: www.muschealth.org/radonc

Related Content

First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Overlay Init